MedTrace Logo

Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea

NCT06282679 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-02-28

No results posted yet for this study

Summary

the goal of this study is to study the clinical efficacy and safety of botox in the treatment of rosacea.

Conditions

  • Rosacea
  • Botulinum Toxin

Interventions

DRUG

Botulinum Toxin Type A Injection [Botox]

you are asked to return to the hospital for follow-up at weeks 2, 4, 8, and 12

Sponsors & Collaborators

  • Nanjing First Hospital, Nanjing Medical University

    lead OTHER

Principal Investigators

  • Jie DAI · The First Affiliated Hospital with Nanjing Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2024-03-01
Completion
2024-06-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06282679 on ClinicalTrials.gov